Yes Bernard, I must concede that I must agree with you and thanks for your thoughts. Here we go, we will cop it again.
TLX Telix gets its foot in the FDA door bringing prostate cancer detection closer to neglected Americans
Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market